Publication | Closed Access
Phase I and pharmacokinetic study of Triapine®, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies
73
Citations
31
References
2007
Year
Advanced Hematologic MalignanciesMedicinePharmacologyPharmacokinetic StudyPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1